TY - JOUR
T1 - Changes in plasma histaminase activity during normal early human pregnancy and pregnancy disorders
AU - Beaven, M. A.
AU - Marshall, J. R.
AU - Baylin, S. B.
AU - Sjoerdsma, A.
PY - 1975
Y1 - 1975
N2 - A sensitive isotopic assay was employed to follow the changes in plasma histaminase activity during pregnancy in patients who become pregnant following spontaneous and induced ovulation. Values in nonpregnant women ranged from 0.2 to 2.7 pmoles of histamine deaminated per milliliter of plasma per hour. In pregnant women, plasma histaminase activity began to increase 9 to 28 days following the presumed day of ovulation and then rose exponentially with a doubling time of 4 to 5 days. Peak values, 1,500 pmoles per milliliter per hour, were reached during the third trimester of pregnancy. The data suggested that the increase in histaminase activity actually started at about the same time in all patients, although the early rise in enzyme activity was not apparent in women who had high histaminase activity before pregnancy. Plasma histaminase did not rise in patients with spontaneous abortion, blighted ovum with hydatidiform degeneration, or choriocarcinoma. The high levels of chorionic gonadotropin and low levels of histaminase activity seen in patients with trophoblastic neoplasia suggest that these tests may be of value in the diagnosis of trophoblastic neoplasia early in pregnancy.
AB - A sensitive isotopic assay was employed to follow the changes in plasma histaminase activity during pregnancy in patients who become pregnant following spontaneous and induced ovulation. Values in nonpregnant women ranged from 0.2 to 2.7 pmoles of histamine deaminated per milliliter of plasma per hour. In pregnant women, plasma histaminase activity began to increase 9 to 28 days following the presumed day of ovulation and then rose exponentially with a doubling time of 4 to 5 days. Peak values, 1,500 pmoles per milliliter per hour, were reached during the third trimester of pregnancy. The data suggested that the increase in histaminase activity actually started at about the same time in all patients, although the early rise in enzyme activity was not apparent in women who had high histaminase activity before pregnancy. Plasma histaminase did not rise in patients with spontaneous abortion, blighted ovum with hydatidiform degeneration, or choriocarcinoma. The high levels of chorionic gonadotropin and low levels of histaminase activity seen in patients with trophoblastic neoplasia suggest that these tests may be of value in the diagnosis of trophoblastic neoplasia early in pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=0016767287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016767287&partnerID=8YFLogxK
U2 - 10.1016/0002-9378(75)90882-0
DO - 10.1016/0002-9378(75)90882-0
M3 - Article
C2 - 812363
AN - SCOPUS:0016767287
VL - 123
SP - 605
EP - 609
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
SN - 0002-9378
IS - 6
ER -